RaySearch Laboratories AB (publ) (RAY-B) - Total Liabilities
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has total liabilities worth Skr984.80 Million SEK (≈ $105.98 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
RaySearch Laboratories AB (publ) - Total Liabilities Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See RaySearch Laboratories AB (publ) (RAY-B) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
RaySearch Laboratories AB (publ) Competitors by Total Liabilities
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Omeros Corporation
NASDAQ:OMER
|
USA | $349.51 Million |
|
Logistea AB Series B
ST:LOGI-B
|
Sweden | Skr9.63 Billion |
|
Elec-Tech International Co Ltd
SHE:002005
|
China | CN¥770.56 Million |
|
Regional Container Lines Public Company Limited
BK:RCL-R
|
Thailand | ฿23.02 Billion |
|
CEWE Stiftung & Co. KGaA
XETRA:CWC
|
Germany | €200.76 Million |
|
Hosken Consolidated Investments Ltd
JSE:HCI
|
South Africa | ZAC24.63 Billion |
|
Admie Holding S.A
AT:ADMIE
|
Greece | €3.19 Billion |
|
Manitou BF S.A.
PA:MTU
|
France | €1.06 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down RaySearch Laboratories AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RAY-B stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RaySearch Laboratories AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual total liabilities of RaySearch Laboratories AB (publ) from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr1.01 Billion ≈ $108.34 Million |
-17.11% |
| 2024-12-31 | Skr1.21 Billion ≈ $130.70 Million |
-0.24% |
| 2023-12-31 | Skr1.22 Billion ≈ $131.02 Million |
-0.11% |
| 2022-12-31 | Skr1.22 Billion ≈ $131.16 Million |
+11.84% |
| 2021-12-31 | Skr1.09 Billion ≈ $117.28 Million |
+84.53% |
| 2020-12-31 | Skr590.55 Million ≈ $63.55 Million |
+5.69% |
| 2019-12-31 | Skr558.76 Million ≈ $60.13 Million |
+24.73% |
| 2018-12-31 | Skr447.97 Million ≈ $48.21 Million |
+33.87% |
| 2017-12-31 | Skr334.64 Million ≈ $36.01 Million |
+30.18% |
| 2016-12-31 | Skr257.07 Million ≈ $27.66 Million |
+55.82% |
| 2015-12-31 | Skr164.97 Million ≈ $17.75 Million |
+19.37% |
| 2014-12-31 | Skr138.21 Million ≈ $14.87 Million |
+34.75% |
| 2013-12-31 | Skr102.56 Million ≈ $11.04 Million |
+35.89% |
| 2012-12-31 | Skr75.47 Million ≈ $8.12 Million |
+17.38% |
| 2011-12-31 | Skr64.30 Million ≈ $6.92 Million |
+8.68% |
| 2010-12-31 | Skr59.16 Million ≈ $6.37 Million |
+22.65% |
| 2009-12-31 | Skr48.24 Million ≈ $5.19 Million |
+28.11% |
| 2008-12-31 | Skr37.66 Million ≈ $4.05 Million |
+6.43% |
| 2007-12-31 | Skr35.38 Million ≈ $3.81 Million |
+25.46% |
| 2006-12-31 | Skr28.20 Million ≈ $3.03 Million |
+11.35% |
| 2005-12-31 | Skr25.33 Million ≈ $2.73 Million |
+99.52% |
| 2004-12-31 | Skr12.69 Million ≈ $1.37 Million |
+16.09% |
| 2003-12-31 | Skr10.94 Million ≈ $1.18 Million |
-- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more